Literature DB >> 9157141

Natural infection of small mammal species in Minnesota with the agent of human granulocytic ehrlichiosis.

J J Walls1, B Greig, D F Neitzel, J S Dumler.   

Abstract

The natural reservoirs for the agent of human granulocytic ehrlichiosis (HGE) are suspected to be the small mammals that host immature stages of Ixodes scapularis ticks. To determine if such small mammals are naturally infected, we collected blood and serum samples from small mammal species in rural and suburban areas of Minneapolis and St. Paul, Minn. Samples were collected from white-footed mice (Peromyscus leucopus), eastern chipmunks (Tamias striatus), southern red-backed voles (Clethrionomys gapperi), and insectivorous shrews (Blarina brevicauda and Sorex cinereus). Blood samples were tested by PCR for active infection with the HGE agent, and sera from P. leucopus mice were tested for serologic evidence of infection by indirect immunofluorescence. PCR analyses revealed the presence of HGE agent DNA in 20 of the 190 samples (10.5%) tested. Of the 119 P. leucopus mouse serum samples that were analyzed, 12 (10.1%) contained Ehrlichia equi antibodies. In 3 of 119 (2.5%) P. leucopus mice from which both blood and serum were collected. HGE agent DNA and antibodies against E. equi were present. Animals with evidence of infection with the HGE agent are widely distributed around the Minneapolis-St. Paul area in regions with known I. scapularis tick activity. Small mammals that are frequent hosts for larval I. scapularis ticks and that are found in areas where HGE occurs are likely to be a major reservoir from which infected ticks that bite humans are derived.

Entities:  

Mesh:

Year:  1997        PMID: 9157141      PMCID: PMC229689          DOI: 10.1128/jcm.35.4.853-855.1997

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  15 in total

1.  Perpetuation of the agent of human granulocytic ehrlichiosis in a deer tick-rodent cycle.

Authors:  S R Telford; J E Dawson; P Katavolos; C K Warner; C P Kolbert; D H Persing
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

2.  Human granulocytic ehrlichiosis: a case series from a medical center in New York State.

Authors:  M E Aguero-Rosenfeld; H W Horowitz; G P Wormser; D F McKenna; J Nowakowski; J Muñoz; J S Dumler
Journal:  Ann Intern Med       Date:  1996-12-01       Impact factor: 25.391

3.  Human granulocytic ehrlichiosis in Massachusetts.

Authors:  S R Telford; T J Lepore; P Snow; C K Warner; J E Dawson
Journal:  Ann Intern Med       Date:  1995-08-15       Impact factor: 25.391

4.  Geographic, clinical, serologic, and molecular evidence of granulocytic ehrlichiosis, a likely zoonotic disease, in Minnesota and Wisconsin dogs.

Authors:  B Greig; K M Asanovich; P J Armstrong; J S Dumler
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

5.  Identification of a granulocytotropic Ehrlichia species as the etiologic agent of human disease.

Authors:  S M Chen; J S Dumler; J S Bakken; D H Walker
Journal:  J Clin Microbiol       Date:  1994-03       Impact factor: 5.948

6.  Babesia microti, human babesiosis, and Borrelia burgdorferi in Connecticut.

Authors:  J F Anderson; E D Mintz; J J Gadbaw; L A Magnarelli
Journal:  J Clin Microbiol       Date:  1991-12       Impact factor: 5.948

7.  Hemocytic rickettsia-like organisms in ticks: serologic reactivity with antisera to Ehrlichiae and detection of DNA of agent of human granulocytic ehrlichiosis by PCR.

Authors:  L A Magnarelli; K C Stafford; T N Mather; M T Yeh; K D Horn; J S Dumler
Journal:  J Clin Microbiol       Date:  1995-10       Impact factor: 5.948

8.  Human granulocytic ehrlichiosis in Wisconsin and Minnesota: a frequent infection with the potential for persistence.

Authors:  J S Dumler; J S Bakken
Journal:  J Infect Dis       Date:  1996-04       Impact factor: 5.226

9.  Clinical and laboratory characteristics of human granulocytic ehrlichiosis.

Authors:  J S Bakken; J Krueth; C Wilson-Nordskog; R L Tilden; K Asanovich; J S Dumler
Journal:  JAMA       Date:  1996-01-17       Impact factor: 56.272

10.  The Ribosomal Database Project.

Authors:  B L Maidak; N Larsen; M J McCaughey; R Overbeek; G J Olsen; K Fogel; J Blandy; C R Woese
Journal:  Nucleic Acids Res       Date:  1994-09       Impact factor: 16.971

View more
  35 in total

1.  Human granulocytic anaplasmosis in the United States from 2008 to 2012: a summary of national surveillance data.

Authors:  F Scott Dahlgren; Kristen Nichols Heitman; Naomi A Drexler; Robert F Massung; Casey Barton Behravesh
Journal:  Am J Trop Med Hyg       Date:  2015-04-13       Impact factor: 2.345

2.  Increasing incidence of Ehrlichia chaffeensis and Anaplasma phagocytophilum in the United States, 2000-2007.

Authors:  F Scott Dahlgren; Eric J Mandel; John W Krebs; Robert F Massung; Jennifer H McQuiston
Journal:  Am J Trop Med Hyg       Date:  2011-07       Impact factor: 2.345

3.  Experimental infection of white-tailed deer with Anaplasma phagocytophilum, etiologic agent of human granulocytic anaplasmosis.

Authors:  Cynthia M Tate; Daniel G Mead; M Page Luttrell; Elizabeth W Howerth; Vivien G Dugan; Ulrike G Munderloh; William R Davidson
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

4.  Characterization of Anaplasma phagocytophilum major surface protein 5 and the extent of its cross-reactivity with A. marginale.

Authors:  N I Strik; A R Alleman; A F Barbet; H L Sorenson; H L Wamsley; F P Gaschen; N Luckschander; S Wong; F Chu; J E Foley; A Bjoersdorff; S Stuen; D P Knowles
Journal:  Clin Vaccine Immunol       Date:  2007-01-10

Review 5.  Coinfections acquired from ixodes ticks.

Authors:  Stephen J Swanson; David Neitzel; Kurt D Reed; Edward A Belongia
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

6.  Prevalence of human-active and variant 1 strains of the tick-borne pathogen Anaplasma phagocytophilum in hosts and forests of eastern North America.

Authors:  Felicia Keesing; Diana J McHenry; Michelle Hersh; Michael Tibbetts; Jesse L Brunner; Mary Killilea; Kathleen LoGiudice; Kenneth A Schmidt; Richard S Ostfeld
Journal:  Am J Trop Med Hyg       Date:  2014-05-27       Impact factor: 2.345

7.  Agents of human anaplasmosis and Lyme disease at Camp Ripley, Minnesota.

Authors:  Russell C Johnson; Carrie Kodner; Janet Jarnefeld; Deborah K Eck; Yaning Xu
Journal:  Vector Borne Zoonotic Dis       Date:  2011-08-25       Impact factor: 2.133

8.  Immunodiagnosis of human granulocytic ehrlichiosis by using culture-derived human isolates.

Authors:  M D Ravyn; J L Goodman; C B Kodner; D K Westad; L A Coleman; S M Engstrom; C M Nelson; R C Johnson
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

9.  Identification of Anaplasma phagocytophila (formerly Ehrlichia phagocytophila) variants in blood from sheep in Norway.

Authors:  Snorre Stuen; Ingrid Van De Pol; Karin Bergström; Leo M Schouls
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

10.  Sequential evaluation of dogs naturally infected with Ehrlichia canis, Ehrlichia chaffeensis, Ehrlichia equi, Ehrlichia ewingii, or Bartonella vinsonii.

Authors:  E B Breitschwerdt; B C Hegarty; S I Hancock
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.